Fine-tuning the immune system's molecular machines

October 08, 2013

WHAT: Immunobiologist Michael Kuhns, The Pew Charitable Trusts' biomedical researcher of the month for his creative work on immunobiology. He studies T cell activation and regulation.

Kuhns aims to decode the "conversations" that take place between those immune cells and other cells in the human body as they work together to respond to infections, vaccines, and growing tumors. His long-term research goal is to develop techniques to manipulate the molecular machinery of the immune system for a desired outcome, such as enhancing response to vaccines or developing therapies to fight tumors.

Kuhns' story is the latest in Pew's biomedical researcher of the month series. Since 1985, the institution's biomedical programs have provided funding to more than 500 early-career investigators who, like Kuhns, show outstanding promise in science with the potential to advance human health. The scholars' exceptional research has earned them Nobel prizes, Lasker awards, MacArthur Foundation "genius" grants and other distinctions.

WHO: Experts are available for interviews regarding Kuhns' research and the program:Pew's biomedical programs include the Pew scholars and the Pew Latin American fellows programs.
WHERE: Visit to view the video profile of Kuhns.

CONTACT: Chelsea Toledo at 202-540-6846,

For information regarding the Pew scholars program in the biomedical sciences, please visit

The Pew Charitable Trusts is driven by the power of knowledge to solve today's most challenging problems. Pew applies a rigorous, analytical approach to improve public policy, inform the public, and stimulate civic life.

Pew Charitable Trusts

Related Vaccines Articles from Brightsurf:

Comprehensive safety testing of COVID-19 vaccines based on experience with prior vaccines
'The urgent need for COVID-19 vaccines must be balanced with the imperative of ensuring safety and public confidence in vaccines by following the established clinical safety testing protocols throughout vaccine development, including both pre- and post-deployment,' write David M.

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Model could improve design of vaccines, immunotherapies
Researchers have discovered a general property for understanding how immune cell receptors sense and respond to microbial signals, which could lead to more effective vaccines for both existing and novel viruses.

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.

Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.

Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.

Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Read More: Vaccines News and Vaccines Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to